Event: 12th International Symposium on Targeted Alpha Therapy (TAT 12)
Date: February 27 - March 2, 2023
Location: Cape Town International Convention Centre 2 (CTICC 2).
TAT 12 will provide information on the newest developments in preclinical studies, clinical experiences, dosimetry and instrumentation, quality assurance, regulatory, targeting, radiochemistry, and nuclide production and supply. Participate in the latest discussions, scientific exchange and in focused networking with industry leaders from around the world.
The Oncidium foundation President, Dr. Richard Zimmermann will be present and will be one of the speaker, don't hesitate to reach out!
More information on TAT 12 >>
Other news & events
- News12.05.2026

#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists
Read more - News11.05.2026

Oncidium foundation partners with Curium to expand access to Radioligand Therapy worldwide
Read more - News22.04.2026

Addressing Barriers to Radioligand Therapy at the European Parliament
Read more




